<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Nassal DM</submitter><funding>American Heart Association</funding><funding>NHLBI NIH HHS</funding><funding>National Institutes of Health</funding><pagination>e17304</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC5338919</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>6</volume><pubmed_abstract>Arrhythmogenesis from aberrant electrical remodeling is a primary cause of death among patients with heart disease. Amongst a multitude of remodeling events, reduced expression of the ion channel subunit KChIP2 is consistently observed in numerous cardiac pathologies. However, it remains unknown if KChIP2 loss is merely a symptom or involved in disease development. Using rat and human derived cardiomyocytes, we identify a previously unobserved transcriptional capacity for cardiac KChIP2 critical in maintaining electrical stability. Through interaction with genetic elements, KChIP2 transcriptionally repressed the miRNAs miR-34b and miR-34c, which subsequently targeted key depolarizing (&lt;i>I&lt;/i>&lt;sub>Na&lt;/sub>) and repolarizing (&lt;i>I&lt;/i>&lt;sub>to&lt;/sub>) currents altered in cardiac disease. Genet</pubmed_abstract><journal>eLife</journal><pubmed_title>KChIP2 is a core transcriptional regulator of cardiac excitability.</pubmed_title><pmcid>PMC5338919</pmcid><funding_grant_id>R01 HL096962</funding_grant_id><funding_grant_id>R01 HL132520</funding_grant_id><funding_grant_id>HL105338-01</funding_grant_id><funding_grant_id>13PRE17060106</funding_grant_id><funding_grant_id>R01HL132520</funding_grant_id><funding_grant_id>R01HL096962</funding_grant_id><pubmed_authors>Liu H</pubmed_authors><pubmed_authors>Maleski D</pubmed_authors><pubmed_authors>Moravec CS</pubmed_authors><pubmed_authors>Laurita KR</pubmed_authors><pubmed_authors>Nassal DM</pubmed_authors><pubmed_authors>Ramirez-Navarro A</pubmed_authors><pubmed_authors>Wan X</pubmed_authors><pubmed_authors>Deschenes I</pubmed_authors><pubmed_authors>Ficker E</pubmed_authors></additional><is_claimable>false</is_claimable><name>KChIP2 is a core transcriptional regulator of cardiac excitability.</name><description>Arrhythmogenesis from aberrant electrical remodeling is a primary cause of death among patients with heart disease. Amongst a multitude of remodeling events, reduced expression of the ion channel subunit KChIP2 is consistently observed in numerous cardiac pathologies. However, it remains unknown if KChIP2 loss is merely a symptom or involved in disease development. Using rat and human derived cardiomyocytes, we identify a previously unobserved transcriptional capacity for cardiac KChIP2 critical in maintaining electrical stability. Through interaction with genetic elements, KChIP2 transcriptionally repressed the miRNAs miR-34b and miR-34c, which subsequently targeted key depolarizing (&lt;i>I&lt;/i>&lt;sub>Na&lt;/sub>) and repolarizing (&lt;i>I&lt;/i>&lt;sub>to&lt;/sub>) currents altered in cardiac disease. Genet</description><dates><release>2017-01-01T00:00:00Z</release><publication>2017 Mar</publication><modification>2026-04-08T17:16:52.62Z</modification><creation>2019-03-27T02:37:56Z</creation></dates><accession>S-EPMC5338919</accession><cross_references><pubmed>28263709</pubmed><doi>10.7554/eLife.17304</doi></cross_references></HashMap>